<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>80(2)</volume><submitter>Mastalerz L</submitter><funding>Narodowe Centrum Nauki</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>15-oxo-eicosatetraenoic acid (15-oxo-ETE), is a product of arachidonic acid (AA) metabolism in the 15-lipoxygenase-1 (15-LOX-1) pathway. 15-oxo-ETE was overproduced in the nasal polyps of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD). In this study we investigated the systemic biosynthesis of 15-oxo-ETE and leukotriene E&lt;sub>4&lt;/sub> (LTE&lt;sub>4&lt;/sub>) and assessed their diagnostic value to identify patients with N-ERD.&lt;h4>Methods&lt;/h4>The study included 64 patients with N-ERD, 59 asthmatics who tolerated aspirin well (ATA), and 51 healthy controls. A thorough clinical characteristics of asthmatics included computed tomography of paranasal sinuses. Plasma and urinary 15-oxo-ETE levels, and urinary LTE&lt;sub>4&lt;/sub> excretion were me</pubmed_abstract><journal>Allergy</journal><pagination>534-544</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11804310</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Aspirin hypersensitivity diagnostic index (AHDI): In vitro test for diagnosing of N-ERD based on urinary 15-oxo-ETE and LTE&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; excretion.</pubmed_title><pmcid>PMC11804310</pmcid><pubmed_authors>Sanak M</pubmed_authors><pubmed_authors>Szaleniec J</pubmed_authors><pubmed_authors>Trad G</pubmed_authors><pubmed_authors>Jakiela B</pubmed_authors><pubmed_authors>Gielicz A</pubmed_authors><pubmed_authors>Mastalerz L</pubmed_authors><pubmed_authors>Plutecka H</pubmed_authors><pubmed_authors>Gawlewicz-Mroczka A</pubmed_authors><pubmed_authors>Szatkowski P</pubmed_authors><pubmed_authors>Kacorzyk R</pubmed_authors><pubmed_authors>Cmiel A</pubmed_authors></additional><is_claimable>false</is_claimable><name>Aspirin hypersensitivity diagnostic index (AHDI): In vitro test for diagnosing of N-ERD based on urinary 15-oxo-ETE and LTE&amp;lt;sub&amp;gt;4&amp;lt;/sub&amp;gt; excretion.</name><description>&lt;h4>Background&lt;/h4>15-oxo-eicosatetraenoic acid (15-oxo-ETE), is a product of arachidonic acid (AA) metabolism in the 15-lipoxygenase-1 (15-LOX-1) pathway. 15-oxo-ETE was overproduced in the nasal polyps of patients with nonsteroidal anti-inflammatory drug-exacerbated respiratory disease (N-ERD). In this study we investigated the systemic biosynthesis of 15-oxo-ETE and leukotriene E&lt;sub>4&lt;/sub> (LTE&lt;sub>4&lt;/sub>) and assessed their diagnostic value to identify patients with N-ERD.&lt;h4>Methods&lt;/h4>The study included 64 patients with N-ERD, 59 asthmatics who tolerated aspirin well (ATA), and 51 healthy controls. A thorough clinical characteristics of asthmatics included computed tomography of paranasal sinuses. Plasma and urinary 15-oxo-ETE levels, and urinary LTE&lt;sub>4&lt;/sub> excretion were me</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Feb</publication><modification>2025-04-04T01:32:42.546Z</modification><creation>2025-04-04T01:32:42.546Z</creation></dates><accession>S-EPMC11804310</accession><cross_references><pubmed>39180224</pubmed><doi>10.1111/all.16281</doi></cross_references></HashMap>